The government clearance for key abortion drug mifepristone was suspended on April 7 in an unprecedented move that saw the US Food and Drug Administration's 23-year-old approval trashed. Since the overturn of Roe v. Wade, the drug has become increasingly significant in the fight over abortion access.
